Biomedical Engineering Reference
In-Depth Information
Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M (2002) Candidemia at a
tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death.
Eur J Clin Microbiol Infect Dis 21(11):767-774
Walraven CJ, Lee SA (2013) Antifungal lock therapy. Antimicrob Agents Chemother 57(1):1-8
Wang X, Du L, You J, King JB, Cichewicz RH (2012) Fungal biofilm inhibitors from a human oral
microbiome-derived bacterium. Org Biomol Chem 10(10):2044-2050
Wiederhold NP, Grabinski JL, Garcia-Effron G, Perlin DS, Lee SA (2008) Pyrosequencing to
detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Antimicrob Agents Chemother 52(11):4145-4148
Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J (2002) The direct cost and
incidence of systemic fungal infections. Value Health 5(1):26-34
You J, Du L, King JB, Hall BE, Cichewicz RH (2013) Small-molecule suppressors of Candida
albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B
against clinical Candida isolates. ACS Chem Biol 8(4):840-848
Search WWH ::
Custom Search